Publications by authors named "M Tsagournisakis"
Article Synopsis
- The Canalith Repositioning Procedure (CRP) is an effective treatment for benign paroxysmal positional vertigo (BPPV), yielding immediate symptom relief in 85% of patients during a study involving 965 participants from 1995-2010.
- Follow-up over an average of 74 months found that 139 patients experienced recurrence of symptoms, with higher rates in older individuals and those with specific medical histories.
- The study concludes that while CRP is a successful non-invasive option for BPPV, elderly patients may require additional support and education to manage their increased risk of recurring symptoms and associated falls.
Bone marrow (BM) stem cell reserves and function and stromal cell hematopoiesis supporting capacity were evaluated in 15 patients with multiple sclerosis (MS) and 61 normal controls using flow cytometry, clonogenic assays, long-term BM cultures (LTBMCs) and enzyme-linked immunosorbent assays. MS patients displayed normal CD34+ cell numbers but a low frequency of colony-forming cells (CFCs) in both BM mononuclear and purified CD34+ cell fractions, compared to controls. Patients had increased proportions of activated BM CD3+/HLA-DR+ and CD3+/CD38+ T cells that correlated inversely with CFC numbers.
View Article and Find Full Text PDFObjective: To assess the long-term efficacy of canalith repositioning procedure (CRP) in the treatment of patients with benign paroxysmal positional vertigo (BPPV).
Background: Alternative theories for the pathophysiology of BPPV have been redefined in the past few years. CRP is considered to be the standard technique for its management.